Article Details
Retrieved on: 2021-03-16 18:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
APR-246 Combo Treatment in TP53-Mutant Relapsed/Refractory NHL. — Upcoming trial will test safety and efficacy in CLL and MCL patients. by Greg ...
Article found on: www.medpagetoday.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here